GLIVEC
Novartis AG
| Research |
OneLook
Acronym Finder
|
| Serial Number | 78471108 |
| Registration Number | 3089522 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Cancellation Code | 2 |
| Domestic Representative | Maury M. Tepper, III |
| Attorney Name | Maury M. Tepper, III |
| Law Office Assigned | M20 |
| Employee Name | BELLO, ZACHARY R |
Timeline
| 2004-08-20 | Application Filed |
| 2005-08-30 | Published for Opposition |
| 2006-05-09 | Location: PUBLICATION AND ISSUE SECTION |
| 2006-05-09 | Trademark Registered |
| 2012-12-14 | Cancelled |
| 2012-12-14 | Status: Dead/Cancelled |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Novartis AG |
| Address | 4002 Basel CH |
| Legal Entity Type | Corporation |
| Legal Entity State | CH |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the respiratory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in hematology, in transplantation, in ophthalmology, for use in the gastroenterological area and for the prevention and treatment of ocular disorders or diseases; anti-infectives, antibacterials, antivirals, antibiotics, antifungals and not for the treatment of diabetes |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2004-08-30 | 1 NWAP I:Incoming Correspondence |
| PAPER RECEIVED | 2004-12-06 | 2 MAIL I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2004-12-19 | 3 TCCA I:Incoming Correspondence |
| APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED | 2004-12-06 | 4 AMPX O:Outgoing Correspondence |
| TEAS VOLUNTARY AMENDMENT RECEIVED | 2005-02-15 | 5 PARI I:Incoming Correspondence |
| APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED | 2005-02-15 | 6 AMPX O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2005-03-10 | 7 DOCK D:Assigned to Examiner |
| PRIORITY ACTION WRITTEN | 2005-03-13 | 8 CPRA R:Renewal |
| PRIORITY ACTION E-MAILED | 2005-03-13 | 9 GPRA F:First Action |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2005-04-13 | 10 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2005-04-13 | 11 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2005-04-22 | 12 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2005-04-23 | 13 CNSA O:Outgoing Correspondence |
| ASSIGNED TO LIE | 2005-04-29 | 14 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2005-05-05 | 15 PREV O:Outgoing Correspondence |
| NOTICE OF PUBLICATION | 2005-08-10 | 16 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2005-08-30 | 17 PUBO A:Allowance for Publication |
| EXTENSION OF TIME TO OPPOSE RECEIVED | 2005-09-29 | 18 ETOF T:TTAB Proceeding |
| PAPER RECEIVED | 2006-02-17 | 19 MAIL I:Incoming Correspondence |
| CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED | 2006-03-24 | 20 CHPB I:Incoming Correspondence |
| EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | 2006-03-29 | 21 ETOP T:TTAB Proceeding |
| REGISTERED-PRINCIPAL REGISTER | 2006-05-09 | 22 R.PR A:Allowance for Publication |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2009-06-18 | 23 TCCA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2009-06-18 | 24 TCCA I:Incoming Correspondence |
| CANCELLED SEC. 8 (6-YR) | 2012-12-14 | 25 C8.. O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 GLIVEC 78471108 3089522 Dead/Cancelled |
Novartis AG 2004-08-20 |
 GLIVEC 78002814 2478196 Dead/Cancelled |
Novartis AG 2000-04-06 |
 GLIVEC 75041940 not registered Dead/Abandoned |
SANDOZ AG (SANDOZ LTD., SANDOZ S.A.) 1996-01-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 